Search - tctmd.com

Displaying 41 - 60 of 980

Sort: Relevancy | Date

Presentation TCT 2021

New Data on Racial Disparities

Presenter: Foluso Fakorede

November 06, 2021

Presentation TCT 2021

Intrepid TA Data Review and Program Update

Presenter: Martin Leon

November 06, 2021

Presentation TCT 2021

Opportunities to Improve Outcomes: IVUS

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Presenter: Renato D. Lopes

November 06, 2021

Presentation TCT 2021

Atherectomy as an Adjunct to Long-term Patency

Presenter: Ravish Sachar

November 06, 2021

Presentation TCT 2021

Role of Drug Eluting Technologies as Definitive Therapy

Presenter: Thomas Zeller

November 06, 2021

Presentation TCT 2021

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Presenter: Brijeshwar Maini

November 06, 2021

Presentation TCT 2021

Case Presentation: Long Segment SFA Occlusion

Presenter: Mohammad Ansari

November 06, 2021

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Presenter: Mohamad A. Alkhouli

November 06, 2021

Presentation TCT 2021

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Connie Hess

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

Presentation TCT 2021

Hybrid Drug Eluting Scaffold for Large Vessel Arterial Drug Delivery

Presenter: Sahil Parikh

November 06, 2021

Presentation TCT 2021

Case #2 Resolution: A Patient With Major Bleeding Post-PCI

Presenter: Kelly Epps

November 06, 2021

Presentation TCT 2021

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

Presenter: Janarthanan Sathananthan

November 06, 2021

Presentation TCT 2021

Directional Versus Orbital Atherectomy of Femoropopliteal Artery Lesions: Angiographic and Intravascular Ultrasound Outcomes

Presenter: Anvar Babaev

November 06, 2021

Advertisement

New Data on Racial Disparities

Intrepid TA Data Review and Program Update

Opportunities to Improve Outcomes: IVUS

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Atherectomy as an Adjunct to Long-term Patency

Role of Drug Eluting Technologies as Definitive Therapy

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Case Presentation: Long Segment SFA Occlusion

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Have We Gotten to the Final Word on Paclitaxel Safety?

Oral Anticoagulation Should Be the Default Strategy After LAAC

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Hybrid Drug Eluting Scaffold for Large Vessel Arterial Drug Delivery

Case #2 Resolution: A Patient With Major Bleeding Post-PCI

Special Considerations of Valve Hemodynamics and Prosthesis-Patient Mismatch Following Valve-in-Valve

Directional Versus Orbital Atherectomy of Femoropopliteal Artery Lesions: Angiographic and Intravascular Ultrasound Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content